GeneDx Holdings (WGS) Change in Inventory (2020 - 2026)

GeneDx Holdings (WGS) has reported Change in Inventory for 7 consecutive years, with -$1.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Inventory fell 183.12% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$285000.0 (down 116.38% YoY), while the FY2025 annual figure was $3.4 million, up 32.92% from the prior year.
• Change in Inventory fell to -$1.7 million in Q1 2026 per WGS's latest filing, from $3.4 million in the prior quarter.
• Across five years, Change in Inventory topped out at $3.4 million in Q4 2025 and bottomed at -$7.6 million in Q4 2022.
• Historically, Change in Inventory has averaged $59235.3 across 5 years, with a median of -$293000.0 in 2023.
• On a YoY basis, Change in Inventory climbed as much as 640.97% in 2025 and fell as far as 379.25% in 2025.
• GeneDx Holdings' Change in Inventory stood at -$7.6 million in 2022, then soared by 96.14% to -$293000.0 in 2023, then soared by 254.95% to $454000.0 in 2024, then jumped by 640.97% to $3.4 million in 2025, then slumped by 150.21% to -$1.7 million in 2026.
• Business Quant data shows WGS's Change in Inventory at -$1.7 million in Q1 2026, $3.4 million in Q4 2025, and -$1.3 million in Q3 2025.